Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Otto

Showing results (391-400 of 400) with videos related to

Pageof 40
Sort By:
You have reached the last page of results.This site can display upto 400 results.
Pediatric Blood & Cancer|November 12, 2022
Absolute lymphocyte count recovery following initial acute myelogenous leukemia therapy: Implications for adoptive cell therapyJohn C Molina, Yimei Li, William R Otto, et al.
Journal of Patient-Reported Outcomes|November 28, 2025
A 10-step guide to standardising patient-reported outcomes data collection in healthcare: insights from the health outcomes observatory (H2O) project on overcoming implementation barriersGemma Galan, Preston Long, Yolima Cossio-Gil, et al.
Pneumologie (Stuttgart, Germany)|November 26, 2020
[Risk Assessment for Patients with Chronic Respiratory and Pulmonary Conditions in the Context of the SARS-CoV-2 Pandemic - Statement of the German Respiratory Society (DGP) with the Support of the German Association of Respiratory Physicians (BdP)]M Lommatzsch, K F Rabe, C Taube, et al.
IJTLD Open|March 17, 2025
Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacyL Kuksa, C Andrejak, B Haecker, et al.
Archives of Gynecology and Obstetrics|October 4, 2016
E Sarasin, M Keller, M K Hohl, et al.
IJTLD Open|June 18, 2025
Clinical best practices for caring for people with expanded resistance to newer TB drugsT Nkomo, Z Udwadia, D Vambe, et al.
Infection Control and Hospital Epidemiology|April 25, 2022
Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemiaCaitlin W Elgarten, William R Otto, Luke Shenton, et al.
IJTLD Open|May 13, 2026
Mental health management in the context of TB care in the WHO European Region: a consensus statementC Vilaplana, O Konstantynovska, O Rzhepishevska, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 2, 2022
Clinical standards for the dosing and management of TB drugsJ W C Alffenaar, S L Stocker, L Davies Forsman, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 24, 2023
Clinical standards for the management of adverse effects during treatment for TBK P Singh, A C C Carvalho, R Centis, et al.
Pageof 40

Showing results (391-400 of 400) with videos related to

Sort By:
Pageof 40
You have reached the last page of results.This site can display upto 400 results.
Pediatric Blood & Cancer|November 12, 2022
Absolute lymphocyte count recovery following initial acute myelogenous leukemia therapy: Implications for adoptive cell therapyJohn C Molina, Yimei Li, William R Otto, et al.
Journal of Patient-Reported Outcomes|November 28, 2025
A 10-step guide to standardising patient-reported outcomes data collection in healthcare: insights from the health outcomes observatory (H2O) project on overcoming implementation barriersGemma Galan, Preston Long, Yolima Cossio-Gil, et al.
Pneumologie (Stuttgart, Germany)|November 26, 2020
[Risk Assessment for Patients with Chronic Respiratory and Pulmonary Conditions in the Context of the SARS-CoV-2 Pandemic - Statement of the German Respiratory Society (DGP) with the Support of the German Association of Respiratory Physicians (BdP)]M Lommatzsch, K F Rabe, C Taube, et al.
IJTLD Open|March 17, 2025
Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacyL Kuksa, C Andrejak, B Haecker, et al.
Archives of Gynecology and Obstetrics|October 4, 2016
E Sarasin, M Keller, M K Hohl, et al.
IJTLD Open|June 18, 2025
Clinical best practices for caring for people with expanded resistance to newer TB drugsT Nkomo, Z Udwadia, D Vambe, et al.
Infection Control and Hospital Epidemiology|April 25, 2022
Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemiaCaitlin W Elgarten, William R Otto, Luke Shenton, et al.
IJTLD Open|May 13, 2026
Mental health management in the context of TB care in the WHO European Region: a consensus statementC Vilaplana, O Konstantynovska, O Rzhepishevska, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 2, 2022
Clinical standards for the dosing and management of TB drugsJ W C Alffenaar, S L Stocker, L Davies Forsman, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 24, 2023
Clinical standards for the management of adverse effects during treatment for TBK P Singh, A C C Carvalho, R Centis, et al.
Pageof 40